How do I buy Aurora Cannabis (ACB) stock?

Buying Aurora Cannabis (ACB) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "ACB", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy ACB by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if ACB is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Aurora Cannabis (ACB) Stock

Q: What is the minimum investment for ACB on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in Aurora Cannabis from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NYQ · ACB

Trade ACB

Key stats

Market cap: $258.31M
Price / Earnings ratio: -2.6x
EPS (TTM): -$1.37
Volume: Loading
52-week high: $6.36
52-week low: $2.56
EPS vs analyst estimate: -1050.0%Q2 FY26 · -$0.19 vs $0.02
Next earnings report: 4 Nov 2026

Source: third-party data provider, as of October 31, 2026

EPS estimate: analyst consensus

Compare with ACB

Technical indicators

RSI 14: 51.18
MACD 12/26/9: -0.00
EMA 9 of MACD: 0.02
MACD histogram: -0.02
SMA 50: $4.04; Price above SMA 50
EMA 50: $3.94; Price above EMA 50
SMA 200: $3.54; Price above SMA 200
EMA 200: $3.82; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of October 29, 2026. Technical data, not a recommendation.

Analyst ratings

No analyst data available

Financials

Performance

Revenue

Net income

Net margin %

2025

2026

286M189M94M0

Debt & Balance Sheet

Total assets

Total liabilities

2025

2026

1B675M338M0

Revenue to Profit

2026

$232.3M

Revenue

$0.0

Cost of revenue

$136.7M

Gross profit

$0.0

Operating expenses

$-164.4M

Net income

Earnings

EPS forecast

Actual EPS

$-0.19

$0.02

Q2FY26

$0.19

Q3FY26

$0.04

Q4FY26

$-0.05

Q1FY27

Q2FY27

The market has no earnings per share expectations for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Aurora Cannabis

Aurora is a pioneer in global cannabis dedicated to helping people improve their health, wellness and lives. Since 2013, with our strength in research and product innovation, we have continually pushed industry standards forward, through  state-of-the-art facility engineering, cannabis breeding, research, and industry-leading product development, creating brands that break through wherever they are launched.  Our diverse product portfolio has been developed to best serve medical, consumer and wellness markets.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees1,028

CEOMr. Miguel Martin

IPO DateJul 11, 2014

HeadquartersEdmonton, AB

Key Executives

Name	Title	Year Born
Mr. Miguel Martin	CEO & Executive Chairman	1973
Ms. Simona King CPA	Chief Financial Officer	1972
Mr. Alex Miller	Executive VP of Operations & Supply Chain	—
Ms. Nathalie Clark	Executive VP, General Counsel & Corporate Secretary	—
Ms. Lori Schick	Executive Vice President of Human Resources	—
Kevin Niland	Senior Director of Strategic Finance - Global FP&A and Investor Relations	—
Ms. Michelle Lefler	Vice President of Communications & Public Relations	—
Mr. Rick Savone	Senior Vice President of Global Government Relations	—
Mr. David Aird	Executive Vice President of Information Technology	—
Mr. Kerry Miller	Managing Director for Australia & New Zealand	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-8.2	-10.0
2022	-27.7	-15.0	+9.3	-23.3	-47.1	-15.9	+4.4	+16.8	-18.7	+16.3	-5.9	-30.1
2023	+14.7	-23.4	-14.7	-10.4	-15.7	+6.2	-2.9	-16.8	+23.9	-21.2	+1.5	+1.7
2024	-20.0	-21.3	+38.5	+114.2	-15.9	-23.1	+32.5	+0.5	+0.7	+0.4	-17.9	-8.2
2025	-18.9	+47.4	-9.5	+6.2	+11.6	-18.6	+3.0	+21.0	+15.3	-13.6	-5.7	-6.8
2026	-6.5	-2.0	-11.9	+2.7	+3.4	-23.4	-0.7	+43.1	-3.7	+4.6

Stocks in the same sector

Amneal Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc

ANIP

ANI Pharmaceuticals Inc

FAQ

Buying Aurora Cannabis (ACB) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "ACB", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy ACB by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Aurora Cannabis from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Aurora Cannabis (ACB) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track ACB's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Aurora Cannabis (ACB) Stock

Key stats

Compare with ACB

Recent news

Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call

Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call

ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus

ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus

Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over

Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over

Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher

Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call

Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call

ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus

ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus

Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over

Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over

Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher

Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher

Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease

Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease

Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation

Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation

Curaleaf raises Aurora Cannabis offer by 25%

Curaleaf raises Aurora Cannabis offer by 25%

Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.

Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.

Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid

Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid

$250,000 in These 3 High-Income ETFs Could Pay You ~$2,800 a Month

$250,000 in These 3 High-Income ETFs Could Pay You ~$2,800 a Month

About Aurora Cannabis

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade